Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Factors, Morbidity, Mortality and Long Term Survival in Patients With Neuromuscular Disorders Admitted in Intensive Care Unit

NCT02685215 is registered in ClinicalTrials.gov with Centre d'Investigation Clinique et Technologique 805 as lead sponsor.

NCT NCT02685215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02685215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Factors, Morbidity, Mortality and Long Term Survival in Patients With Neuromuscular Disorders Admitted in Intensive Care Unit
Lead sponsor
Centre d'Investigation Clinique et Technologique 805
Phase
Observational
Overall status
Unknown status
Start date
March 31, 2016
Completion date
December 31, 2019
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intensive care (icu) myopathy, muscular dystrophies